Skip to main content

Twitter-1950293595153391765

Submitted by ryadav-admin on
Feed type
Twitter-AtricureCEO
Post created date
2025-07-29
Post ID
1950293595153391765

Our stellar results reflect the power of innovation and the growing impact of our expanding portfolio, particularly in our AtriClip platform and cryoSPHERE device offerings.

Post URL
https://t.co/oKJolCfb9Z
Post creted timestamp

Twitter-1950209840015380491

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-29
Post ID
1950209840015380491

10–20% of CABG patients have Afib, yet CABG has the lowest rate of surgical ablation—leaving many patients undertreated.​​

The impact?​​

Increased stroke risk​ and reduced long-term survival​.

Post video URL
https://video.twimg.com/ext_tw_video/1950209761208676352/pu/vid/avc1/320x570/C7L1snry5TL_OzrJ.mp4?tag=12
Post URL
https://t.co/gsd0iu96KS
Post creted timestamp

Twitter-1949899000808649004

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-28
Post ID
1949899000808649004

Join us for an upcoming workshop designed for advanced practice providers, PAs, RNs and NPs to explore patient selection, procedural techniques, care team collaboration, and more.​

Register at: <a href="https://t.co/ezXgANn9k2&quot; target="_blank">https://t.co/ezXgANn9k2</a&gt; ​
​
<a href="https://twitter.com/hashtag/MedEd?src=hashtag_click&quot; target="_blank">#MedEd</a> <a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a>

Post video URL
https://video.twimg.com/ext_tw_video/1949898920986816512/pu/vid/avc1/320x568/pCJ5NXZ8JPia8oN0.mp4?tag=12
Post URL
https://t.co/ZjHHMwBSdH
Post creted timestamp

Twitter-1948397942349480245

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-24
Post ID
1948397942349480245

Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.​
​
Learn more about transitional pain: <a href="https://t.co/rbGp7fDgpa&quot; target="_blank">https://t.co/rbGp7fDgpa</a&gt;

Post video URL
https://video.twimg.com/ext_tw_video/1948397787969679360/pu/vid/avc1/320x570/WGR4yRKl8ZeeVxaX.mp4?tag=12
Post URL
https://t.co/zYRoBpB5gd
Post creted timestamp

Twitter-1948035545008922752

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-23
Post ID
1948035545008922752

Individuals with symptomatic IST typically have heart rates greater than 100 bpm even with minimal activity. For those who don’t respond to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.​ Learn more:

Post image URL
https://pbs.twimg.com/media/GwjQANWXcAETz9G.png
Post URL
https://t.co/gwQDXBLpcw
Post creted timestamp

Facebook-171059586426348_1340230991440038

Submitted by ryadav-admin on
Feed type
Facebook
Post created date
2025-07-23T15:00:37+0000
Post ID
171059586426348_1340230991440038

Individuals with symptomatic IST typically have heart rates greater than 100 beats per minute even with minimal activity. ​
​
The HEAL-IST Trial is currently enrolling patients to evaluate whether a hybrid sinus node sparing procedure is a safe and effective treatment option for symptomatic and drug-resistant IST patients.​

See candidate qualifications at: heal-ist.com <a href="https://www.facebook.com/hashtag/

IST" target="_blank">

#IST</a> <a href="https://www.facebook.com/hashtag/InnapropriateSinusTachycardia&quot; target="_blank">#InnapropriateSinusTachycardia</a> <a href="https://www.facebook.com/hashtag/ClinicalTrial&quot; target="_blank">#ClinicalTrial</a>

Post image URL
https://scontent-iad3-1.xx.fbcdn.net/v/t39.30808-6/521895844_1340230934773377_3668537340852190252_n.jpg?stp=dst-jpg_p720x720_tt6&_nc_cat=102&ccb=1-7&_nc_sid=127cfc&_nc_ohc=k48zppS0VekQ7kNvwG-hRDj&_nc_oc=AdlisYutrvmssj7Hs3nzoH00Wk3fjYcoMoX5YfV_pHCuDfQCwocxdqQhklGTGi_hUjU&_nc_zt=23&_nc_ht=scontent-iad3-1.xx&edm=AKIiGfEEAAAA&_nc_gid=G2tBYZx79sor2ri-UjV4JA&oh=00_AfUeiscJoRUkGrvCTKfyHSGWXM6N5l0p5amCgBnNv7rnKg&oe=68B3B4E1
Post URL
https://www.facebook.com/513124590817353/posts/1340230991440038
Post creted timestamp

LinkedIn-EUROPE-urn:li:ugcPost:7353731537512583169

Submitted by ryadav-admin on
Feed type
LinkedIn - Europe
Post created date
1753266224
Post ID
urn:li:ugcPost:7353731537512583169

Dr. Richard Whitlock, the principal investigator of the LAAOS III trial, emphasized that his preferred method to achieve left atrial appendage exclusion is surgical occlusion during cardiac surgery in patients with atrial fibrillation who are at risk of stroke.​

The LAAOS III trial demonstrated that prophylactic LAA occlusion during heart surgery significantly reduces the long-term risk of stroke in patients with AF. ​

Learn more about LAA exclusion to reduce stroke risk* at: <a href="https://lnkd.in/e3Sz5ifs&quot; target="_blank">https://lnkd.in/e3Sz5ifs</a&gt; ​

*Originating from the LAA​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAE&highlightedUpdateU…; target='_blank'>#LAAE</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ReduceStrokeRisk&highli…; target='_blank'>#ReduceStrokeRisk</a>​
​

Post video URL
https://dms.licdn.com/playlist/vid/v2/D4E05AQGNv6VdHi4S9Q/mp4-640p-30fp-crf28/B4EZg2z3rSHgBw-/0/1753266273397?e=1756904400&v=beta&t=1KTadIsLPhS9CssUf_UQpfJA7C3-NPlId_0EcAHan0E
Post URL
https://www.linkedin.com/feed/update/urn:li:ugcPost:7353731537512583169
Post creted timestamp

Twitter-1947673111186292832

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-22
Post ID
1947673111186292832

Backed by over a decade of clinical evidence, LAAE is a Class IA recommendation from AHA, ACC &amp; STS.​

The AtriClip® FLEX-Mini™ is the newest, lowest-profile device in our full LAAE portfolio—designed for gold-standard care.​
​
Learn more: <a href="https://t.co/JEybEUFTho&quot; target="_blank">https://t.co/JEybEUFTho</a&gt;

<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Post image URL
https://pbs.twimg.com/media/GweGX1qWIAEa_Is.png
Post URL
https://t.co/07cvAx0TUS
Post creted timestamp

Twitter-1947310750994673847

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-21
Post ID
1947310750994673847

Designed for patients with long-standing persistent Afib, the EPi-Sense ST™ System is the only FDA-approved device for minimally invasive ablation therapy to treat LSPAF.​

Discover how EPi-Sense ST™ is helping address the most undertreated Afib population:

Post image URL
https://pbs.twimg.com/media/GwY8znsW0AA3iCx.png
Post URL
https://t.co/jTCHPAMIcE
Post creted timestamp

Twitter-1946223680863838587

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-18
Post ID
1946223680863838587

The AtriClip® FLEX-Mini™ delivers continuous closing pressure through easy one-handed, suture-less deployment for enhanced surgical control.​

Discover the lowest-profile surgical LAAE device: <a href="https://t.co/3PxTkDVSXP&quot; target="_blank">https://t.co/3PxTkDVSXP</a&gt; ​

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a> <a href="https://twitter.com/hashtag/LAAE?src=hashtag_click&quot; target="_blank">#LAAE</a>

Post video URL
https://video.twimg.com/ext_tw_video/1946223658940153857/pu/vid/avc1/320x400/o5hRh8IVQdvWXBgv.mp4?tag=12
Post URL
https://t.co/tmIfHhY2mQ
Post creted timestamp
Subscribe to